Acupuncture for Gilles de la Tourette's syndrome

Cochrane Database of Systematic Reviews

Volumn , Issue 2, 2009, Pages

  Cui, Ye ^a   Liu, Zhishun ^b   Zhang, Wei ^b  

^a BEIJING UNIVERSITY OF CHINESE MEDICINE   (China)

^b INSTITUTE OF CHINESE MATERIA MEDICA   (China)

Author keywords

[No Author keywords available]

Indexed keywords

HERBACEOUS AGENT;

ACUPUNCTURE; ADVERSE OUTCOME; CLINICAL TRIAL; DISEASE SEVERITY; ELECTROACUPUNCTURE; GILLES DE LA TOURETTE SYNDROME; HUMAN; INTERMETHOD COMPARISON; META ANALYSIS; OBSESSIVE COMPULSIVE DISORDER; OUTCOME ASSESSMENT; PATIENT SAFETY; PSYCHOTHERAPY; REVIEW; SHAM PROCEDURE; SYSTEMATIC REVIEW; THERAPY EFFECT;

EID: 70349131579     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD007832     Document Type: Review

References (31)

1. Abelson JF, Kwan KY, O'Roak BJ, Baek DY, Stillman AA, Morgan TM, et al.Sequence variants in SLITRK1 are associated with Tourette's syndrome. Science 2005;310:317-320
2. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edition, text revision (DSM-IV-TR). Washington, DC: APA, 2000.
3. Arzimanoglou AA. Gilles de la Tourette syndrome. Journal of Neurology 1998;245:761-765
4. Curtis A, Clarke CE, Rickards H. Cannabinoids in Tourette's syndrome. Cochrane Database of Systematic Reviews 2007, Issue 2.[Art. No.: CD006565. DOI: 10.1002/14651858.CD006565]
5. Dharmananda S. Tourette's syndrome: Potential Treatments with Chinese Medicine. http://www.itmonline.org/arts/tourettes.htm (accessed 7 September 2007).
6. Dion Y, Annable L, Sandor P, Chouinard G. Risperidone in the treatment of Tourette syndrome: a double-blind, placebo controlled trial. Journal of Clinical Psychopharmacology 2002;22(1):31-39
7. Du GS. Observations on the curative effect of acupuncture on child Tourette's syndrome. Shanghai Journal of Acupuncture and Moxibustion 2007;26(3):5-6.
8. EggerM, Smith GD, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315:629-634
9. Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions 4.2.5 [updated May 2005]. In: The Cochrane Library, issue 3, 2005. Chichester, UK: John Wiley & Sons Ltd.
10. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, et al.Assessing the quality of reports of randomized clinical trials: is blinding necessary?. Controlled Clinical Trials 1996;17:1-12.
11. Jankovic J. Tourette's syndrome. New England Journal of Medicine 2001;345:1184-1192
12. Kindler J, Schosser A, Stamenkovic M, Schloegelhofer M, Leisch F, Hornik K, et al.Tourette's syndrome is not associated with interleukin-10 receptor 1 variants on chromosome 11q23.3. Psychiatry Research 2008;157:235-239
13. Kjaergard LL, Villumsen J,Gluud C. Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses. Annals of Internal Medicine 2001;135(11):982-989
14. Leckman JF, Cohen DJ. Evolving models of pathogenesis (chapter 9). Leckman JF, Cohen DJ. Tourette's syndrome - tics, obsessions, compulsions: developmental psychopathology and clinical care. New York: Wiley, 1999:155-176
15. Leckman JF. Tourette's syndrome. Lancet 2002;360:1577-1586
16. Ma XP, Zhao CY, Cui YH, Zhu Y. Treatment of 102 cases of Tourette's syndrome with acupuncture plus herbal medicine. Journal of Acupuncture and Tuina Science 2007;5:252-254
17. Mantel BJ, Meyers A, Tran QY, Rogers S, Jacobson JS. Nutritional supplements and complementary/alternative medicine in Tourette syndrome. Journal of Child and Adolescent Psychopharmacology 2004;14:582-589
18. Moher D, PhamB, Jones A, Cook DJ, Jadad A,MoherM, et al.Does quality of reports of randomized trials affect estimates of intervention efficacy reported in meta-analysis?. Lancet 1998;352:609-613
19. Pauls DL. An update on the genetics of Gilles de la Tourette syndrome. Journal of Psychosomatic Research 2003;55:7-12.
20. Robertson MM, Stern JS. Tic disorders: new developments in Tourette syndrome and related disorders. Current Opinion in Neurology 1998;11:373-380
21. Robertson MM. Tourette syndrome, associated conditions and the complexities of treatment. Brain 2000;123(3):425-462
22. Robertson MM, Stern JS. Gilles de la Tourette Syndrome: symptomatic treatment based on evidence. European Child and Adolescent Psychiatry 2000;9(Suppl. 1):60-75.
23. Robertson MM. The Gilles de la Tourette syndrome: an update. Psychiatry 2004;3(8):3-7.
24. Robertson MM, Cavanna AE. The Gilles de la Tourette Syndrome: a principal component factor analytic study of a large pedigree. Psychiatric Genetics 2007;17:143-152
25. Scahill L, Leckman JF, Schultz RT, Katsovich L, Peterson BS. A placebo-controlled trial of risperidone in Tourette syndrome. Neurology 2003;60(7):1130-1135
26. Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias: dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995;273:408-412
27. Singer HS, Wendlandt J, Krieger M, Giuliano J. Baclofen treatment in Tourette syndrome: a double-blind, placebo-controlled, crossover trial. Neurology 2001;56:599-604.
28. Stern JS. Tourette's and tics. Current Paediatrics 2006;16:459-463
29. Swain J, Scahill L, Lombroso PJ, King RA, Leckman JF. Tourette syndrome and tic disorders: a decade of progress. Journal of the American Academy of Child and Adolescent Psychiatry 2007;46(8):947-968
30. World Health Organization. Multiaxial Classification of Child and Adolescent Psychiatric Disorders. International Classification of Diseases and Related Health Problems, 10th Revision (ICD-10). Cambridge: Cambridge University Press, 1998.
31. Wu L, Li H, Kang L. 156 cases of Gilles de la Tourette's syndrome treated by acupuncture. Journal of Traditional Chinese Medicine 1996;16(3):211-3.